The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q34092884
Bortezomib for the treatment of multiple myelomaCost-effectiveness of bortezomib for multiple myeloma: a systematic review(125)I particle implantation combined with chemoradiotherapy to treat advanced pancreatic cancer.Bortezomib in multiple myeloma: systematic review and clinical considerations.Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levelsCellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide maiEfficient allocation of novel agents in multiple myeloma: a work in progressEconomic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis.Cost-Effectiveness of Autologous Stem Cell Treatment as Compared to Conventional Chemotherapy for Treatment of Multiple Myeloma in India.Systematic review of the economic evaluations of novel therapeutic agents in multiple myeloma: what is the reporting quality?Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma.The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.Treatment of hepatic metastases with computed tomography-guided interstitial brachytherapy.
P2860

The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.

Item
http://www.wikidata.org/entity/Q34092884
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
type
label
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
prefLabel
The clinical effectiveness and ...... eview and economic evaluation.
@ast
The clinical effectiveness and ...... eview and economic evaluation.
@en
The clinical effectiveness and ...... eview and economic evaluation.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
The clinical effectiveness and ...... eview and economic evaluation.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932